Biotage Makes a Change in Top Management after Business Area President Resigns
News Feb 28, 2006
Biotage has announced the change in its top management. David Patteson, President of the business area Discovery Chemistry has decided to seek new challenges elsewhere. He will leave the company on 1 April 2006.
David Patteson has been with Biotage for seven years during which time he has successfully built up the Global operations. In the last years he also led the integration of the acquired companies and the cost reductions that followed.
The forthcoming CEO of Biotage, Torben Jorgensen, will take over Mr Patteson's responsibilities with immediate effect and work alongside him until 1 April.
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE